Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2017

01-07-2017 | Letter to the Editor

Pyogenic brain abscesses treated with antibiotics in a patient with hemophagocytic lymphohistiocytosis on HLH-94 protocol

Authors: Rochelle Castillo, Aadhar Patil, Victoria Forbes

Published in: Annals of Hematology | Issue 7/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Filipovich A, McClain K, Grom A (2017) Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant 16(1):S82–S89CrossRef
2.
Henter J, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH et al (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100(7):2367–2373CrossRefPubMed
3.
Kim MM, Yum MS, Choi HW, Ko TS, Im HJ, Seo JJ et al (2012) Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Korean J Hematol 47:273–280CrossRefPubMedPubMedCentral
4.
Henter JI, Nennesmo I (1997) Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 130(3):358–365CrossRefPubMed
5.
Haddad E, Sulis ML, Jabado N et al (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 89(3):794–800PubMed
6.
Fitzgerald NE, MacClain KL (2003) Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 33(6):392–401CrossRefPubMed
7.
Ozgen B, Karli-Oguz K, Sarikaya B, Tavil B, Gurgey A (2006) Diffusion-weighted cranial MR imaging findings in a patient with hemophagocytic syndrome. Am J Neuroradiol 27(6):1312 LP–1311314
8.
Horne A, Wickström R, Jordan MB, Yeh EA, Naqvi A, Henter JI, Janka G (2017) How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis? Curr Treat Options Neurol 19(1):3CrossRefPubMedPubMedCentral
9.
Metadata
Title
Pyogenic brain abscesses treated with antibiotics in a patient with hemophagocytic lymphohistiocytosis on HLH-94 protocol
Authors
Rochelle Castillo
Aadhar Patil
Victoria Forbes
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 7/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3011-0

Other articles of this Issue 7/2017

Annals of Hematology 7/2017 Go to the issue

Letter to the Editor

Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma: methodological issues to avoid misinterpretation

Erratum

Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

Review Article

Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib

Original Article

Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography

Original Article

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial

Original Article

Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits